Zinforo

Zinforo

ceftaroline fosamil

Manufacturer:

Pfizer
Concise Prescribing Info
Contents
Ceftaroline fosamil
Indications/Uses
Complicated skin & soft tissue infections (cSSTI) in adult (≥18 yr) caused by susceptible isolates of the designated microorganisms eg, Staphylococcus aureus (including methicillin-susceptible & resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Escherichia coli, Klebsiella pneumoniae & Klebsiella oxytoca.
Dosage/Direction for Use
Adult ≥18 yr 600 mg IV infusion over 60 min every 12 hr for 5-14 days. CrCl >30 to ≤50 mL/min 400 mg every 12 hr over 60 min.
Contraindications
Hypersensitivity to ceftaroline & other cephalosporins. Severe & immediate hypersensitivity to β-lactam antibiotics (eg, penicillins or carbapenems).
Special Precautions
History of hypersensitivity to cephalosporins, penicillins or other β-lactam antibacterials. Discontinue treatment if severe hypersensitivity, C. difficile-associated diarrhoea occurs. Preexisting seizure disorder. Development of positive direct antiglobulin test may occur during treatment. Superinfections may occur. May affect ability to drive & use machines. Renal impairment. Not to be used during pregnancy. Lactation. Childn.
Adverse Reactions
Positive Coombs direct test. Diarrhoea, nausea, vomiting, abdominal pain; headache, dizziness; rash, pruritus; increased transaminases; phlebitis; pyrexia, infusion site reactions (erythema, phlebitis, pain).
MIMS Class
ATC Classification
J01DI02 - ceftaroline fosamil ; Belongs to the class of other cephalosporins and penems. Used in the systemic treatment of infections.
Presentation/Packing
Form
Zinforo powd for conc for soln for infusion 600 mg
Packing/Price
(vial) 10 × 1's (Rp5,320,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in